Biogen Wants MS Drug Approved Globally, CEO Says

Biogen Wants MS Drug Approved Globally, CEO Says Play

April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)

  • On Air Now

    Street Smart with Trish Regan and Adam Johnson Watch Now

  • Next

    Taking Stock with Pimm Fox

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus